Skip to main content

Table 1 Patient characteristics

From: Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy

Clinicopathologic variables RT CCRT CCRT + CT P value
(N = 13) (N = 15) (N = 5)
Age     
≤50 3 4 1 0.558
>50 10 11 4  
Cell type     
Squamous 12 13 5 0.329
Non-squamous 1 2 0  
Tumor grade     
I 1 1 0 0.583
II 9 10 3  
III 3 4 2  
Stage     
IB1 1 2 0 0.782
IB2 8 9 3  
IIA1 2 3 1  
IIA2 2 1 1  
Risk factors     
LTS only 1 2 0 0.489
DSI only 7 7 3  
LVSI only 0 0 0  
LTS + DSI 5 5 2  
LTS + LVSI 0 0 0  
DSI + LVSI 0 1 0  
LTS + DSI + LVSI 0 0 0  
  1. Abbreviations:RT radiotherapy, CCRT chemoradiotherapy, CCRT + CT chemoradiotherapy plus consolidation chemotherapy, LTS large tumor size, DSI deep stromal invasion, LVSI lymphovascular space involvement.